MarketWatch: FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, report says

MarketWatch: FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, report says. “The U.S. Food and Drug Administration has widened its investigation into AstraZeneca’s COVID-19 vaccine study, according to a report, raising the prospect of further delays. AstraZeneca and its partner, the University of Oxford, voluntarily paused its Phase 3 vaccine study worldwide on Sept. 9, after a volunteer in the U.K. developed an ‘unexplained illness.'”

Leave a Reply